It is now 2 months since CytoDyn was going to report the
It is now 2 months since CytoDyn was going to report the 700 NASH numbers. This affects the share price.
The Brazil trial was scheduled to finish in February which came and went. Are there results. This affects the share price.
Same for HIV/BLA and mTNBC. They affect the share price.
"In a timely manner" is up for discussion, but when you get rid of the CEO and there is NO reason given, that affects the share price.
You don't need to put out a PR, just contact one of the members of this board and we can PM each other. My last 5 months has been an advocate for Leronlimab for Long Haulers and we have been completely left out in the cold.
3
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding the Primo Brands Legal Situation Investors should be aware that Primo Brands Corporation (NYSE: PRMB) is currently facing a significant lawsuit related to its recent merger. As the January deadline approaches, many are urged to take action regarding their investments. Key Allegations Against Primo Brands The lawsuit, led by the law firm Hagens Berman, raises...
Continue Reading
Hydration Made Easy with REFRSH The holiday season is often filled with celebrations and indulgence, making it tough to maintain healthy habits. This is where Magnum Nutraceuticals' REFRSH comes into play. This on-the-go supplement aims to simplify the process of staying hydrated by providing a blend of essential nutrients that are both effective and delicious. Packed...
Continue Reading
Unleash Your Summer Adventures with Ruko's U11MINI 4K Drone Ruko, known for making drones accessible and enjoyable, is promoting the outstanding U11MINI 4K Drone, a lightweight marvel that is perfect for both novices and those who love outdoor activities. This drone makes an excellent companion for summer excursions, whether you're camping, hiking, or enjoying outdoor...
Continue Reading
Birchtree Investments Announces New Financing Plans Birchtree Investments Ltd. (CSE: BRCH), an innovative investment firm, is excited to share its plans for a proposed non-brokered private placement. This initiative is aimed at raising up to $1 million by offering common shares priced at $0.02 each. The company’s long-term objective is to strategically divest its...
Continue Reading
inKind just bagged $450 million to fuel its mission of funding up to 10,000 restaurants across the U. S. in a year. This marks a significant leap for the Austin-based company that has already funneled over $600 million into more than 6,000 top eateries while delivering a whopping $175 million in dining rewards for over four million users. The latest cash influx is set to...
Continue Reading
